Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Johnson and Johnson
Mallinckrodt
Moodys
Colorcon

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077944

See Plans and Pricing

« Back to Dashboard

NDA 077944 describes MELOXICAM, which is a drug marketed by Anda Repository, Apotex Inc, Aurobindo Pharma, Breckenridge Pharm, Cipla, Cr Double Crane, Dr Reddys Labs Inc, Glenmark Generics, Heritage Pharma, Impax Labs Inc, Lupin Pharms, Mylan, Puracap Pharm, Roxane, Strides Pharma, Sun Pharm Inds Inc, Taro, Unichem, Yabao Pharm, Yung Shin Pharm, and Zydus Pharms Usa, and is included in twenty-two NDAs. It is available from forty-one suppliers. Additional details are available on the MELOXICAM profile page.

The generic ingredient in MELOXICAM is meloxicam. There are twenty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
Summary for 077944
Tradename:MELOXICAM
Applicant:Lupin Pharms
Ingredient:meloxicam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 077944
Mechanism of ActionCyclooxygenase Inhibitors
Suppliers and Packaging for NDA: 077944
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MELOXICAM meloxicam TABLET;ORAL 077944 ANDA Bryant Ranch Prepack 63629-6707 63629-6707-1 60 TABLET in 1 BOTTLE (63629-6707-1)
MELOXICAM meloxicam TABLET;ORAL 077944 ANDA Bryant Ranch Prepack 63629-6707 63629-6707-2 30 TABLET in 1 BOTTLE (63629-6707-2)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:Jul 19, 2006TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Jul 19, 2006TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Harvard Business School
Baxter
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.